nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—bone cancer—skin cancer	0.198	0.396	CtDrD
Cisplatin—germ cell cancer—skin cancer	0.158	0.314	CtDrD
Cisplatin—peripheral nervous system neoplasm—skin cancer	0.145	0.29	CtDrD
Cisplatin—PTGS2—skin cancer	0.104	1	CbGaD
Cisplatin—ABCC6—Dactinomycin—skin cancer	0.0758	0.286	CbGbCtD
Cisplatin—ABCC5—Fluorouracil—skin cancer	0.0392	0.148	CbGbCtD
Cisplatin—ABCG2—Vismodegib—skin cancer	0.0285	0.108	CbGbCtD
Cisplatin—ABCC3—Fluorouracil—skin cancer	0.0246	0.093	CbGbCtD
Cisplatin—ABCG2—Vemurafenib—skin cancer	0.0225	0.0851	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—skin cancer	0.015	0.0565	CbGbCtD
Cisplatin—CYP2C9—Vismodegib—skin cancer	0.0106	0.04	CbGbCtD
Cisplatin—ABCB1—Vismodegib—skin cancer	0.0103	0.0388	CbGbCtD
Cisplatin—ABCG2—Fluorouracil—skin cancer	0.0101	0.0382	CbGbCtD
Cisplatin—ABCC2—Docetaxel—skin cancer	0.00855	0.0323	CbGbCtD
Cisplatin—ABCG2—Docetaxel—skin cancer	0.00773	0.0292	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—skin cancer	0.0054	0.0204	CbGbCtD
Cisplatin—CYP2C9—Fluorouracil—skin cancer	0.00376	0.0142	CbGbCtD
Cisplatin—ABCC6—dermis—skin cancer	0.00328	0.076	CbGeAlD
Cisplatin—SOD1—Dopamine metabolism—TYR—skin cancer	0.003	0.187	CbGpPWpGaD
Cisplatin—ABCB1—Docetaxel—skin cancer	0.00279	0.0105	CbGbCtD
Cisplatin—NQO1—Dopamine metabolism—TYR—skin cancer	0.00255	0.159	CbGpPWpGaD
Cisplatin—SLC31A2—hair follicle—skin cancer	0.00122	0.0282	CbGeAlD
Cisplatin—ATP7A—endothelium—skin cancer	0.00109	0.0253	CbGeAlD
Cisplatin—ATP7A—hair follicle—skin cancer	0.00107	0.0249	CbGeAlD
Cisplatin—ATP7A—blood vessel—skin cancer	0.00101	0.0233	CbGeAlD
Cisplatin—SOD1—hair follicle—skin cancer	0.000939	0.0218	CbGeAlD
Cisplatin—SLC31A1—hair follicle—skin cancer	0.000915	0.0212	CbGeAlD
Cisplatin—GSTM1—blood vessel—skin cancer	0.000837	0.0194	CbGeAlD
Cisplatin—SLC31A2—nipple—skin cancer	0.000825	0.0191	CbGeAlD
Cisplatin—GSTT1—neck—skin cancer	0.000813	0.0188	CbGeAlD
Cisplatin—ATP7A—nipple—skin cancer	0.000727	0.0169	CbGeAlD
Cisplatin—MT1A—connective tissue—skin cancer	0.000715	0.0166	CbGeAlD
Cisplatin—ABCC5—hair follicle—skin cancer	0.000669	0.0155	CbGeAlD
Cisplatin—SOD1—nipple—skin cancer	0.000636	0.0147	CbGeAlD
Cisplatin—SLC31A1—nipple—skin cancer	0.00062	0.0144	CbGeAlD
Cisplatin—GSTM1—neck—skin cancer	0.000599	0.0139	CbGeAlD
Cisplatin—MT2A—connective tissue—skin cancer	0.000596	0.0138	CbGeAlD
Cisplatin—MPO—endothelium—skin cancer	0.000585	0.0136	CbGeAlD
Cisplatin—PTGS2—leg—skin cancer	0.000574	0.0133	CbGeAlD
Cisplatin—GSTP1—hair follicle—skin cancer	0.000559	0.013	CbGeAlD
Cisplatin—MPO—blood vessel—skin cancer	0.00054	0.0125	CbGeAlD
Cisplatin—MT2A—skin of body—skin cancer	0.000538	0.0125	CbGeAlD
Cisplatin—ATP7A—connective tissue—skin cancer	0.000516	0.012	CbGeAlD
Cisplatin—PTGS2—hindlimb—skin cancer	0.000512	0.0119	CbGeAlD
Cisplatin—ABCC5—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000508	0.0317	CbGpPWpGaD
Cisplatin—MT1A—female reproductive system—skin cancer	0.000504	0.0117	CbGeAlD
Cisplatin—ATP7A—epithelium—skin cancer	0.00049	0.0113	CbGeAlD
Cisplatin—SLC31A2—mammalian vulva—skin cancer	0.000482	0.0112	CbGeAlD
Cisplatin—ABCC6—connective tissue—skin cancer	0.000473	0.011	CbGeAlD
Cisplatin—ATP7B—female reproductive system—skin cancer	0.000452	0.0105	CbGeAlD
Cisplatin—PTGS2—appendage—skin cancer	0.00044	0.0102	CbGeAlD
Cisplatin—MT2A—lymphoid tissue—skin cancer	0.000435	0.0101	CbGeAlD
Cisplatin—GSTM1—connective tissue—skin cancer	0.000429	0.00995	CbGeAlD
Cisplatin—GSTT1—lymphoid tissue—skin cancer	0.000426	0.00988	CbGeAlD
Cisplatin—ATP7A—mammalian vulva—skin cancer	0.000425	0.00984	CbGeAlD
Cisplatin—NQO1—nipple—skin cancer	0.000424	0.00983	CbGeAlD
Cisplatin—MT2A—female reproductive system—skin cancer	0.00042	0.00973	CbGeAlD
Cisplatin—NQO1—neck—skin cancer	0.00042	0.00973	CbGeAlD
Cisplatin—SLC31A2—female reproductive system—skin cancer	0.000413	0.00957	CbGeAlD
Cisplatin—GSTT1—female reproductive system—skin cancer	0.000411	0.00953	CbGeAlD
Cisplatin—GSTM1—skin of body—skin cancer	0.000388	0.00898	CbGeAlD
Cisplatin—GSTP1—nipple—skin cancer	0.000379	0.00879	CbGeAlD
Cisplatin—ATP7B—head—skin cancer	0.000377	0.00875	CbGeAlD
Cisplatin—GSTP1—neck—skin cancer	0.000375	0.0087	CbGeAlD
Cisplatin—ABCC3—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000375	0.0234	CbGpPWpGaD
Cisplatin—SOD1—mammalian vulva—skin cancer	0.000372	0.00861	CbGeAlD
Cisplatin—PTGS2—skin epidermis—skin cancer	0.000366	0.00847	CbGeAlD
Cisplatin—SLC31A1—mammalian vulva—skin cancer	0.000362	0.0084	CbGeAlD
Cisplatin—XDH—mammalian vulva—skin cancer	0.000358	0.00829	CbGeAlD
Cisplatin—MT2A—head—skin cancer	0.000351	0.00813	CbGeAlD
Cisplatin—SLC31A2—head—skin cancer	0.000345	0.00799	CbGeAlD
Cisplatin—GSTT1—head—skin cancer	0.000343	0.00796	CbGeAlD
Cisplatin—SOD1—FOXA1 transcription factor network—SHH—skin cancer	0.000335	0.0209	CbGpPWpGaD
Cisplatin—GSTM1—lymphoid tissue—skin cancer	0.000314	0.00728	CbGeAlD
Cisplatin—SLC31A1—female reproductive system—skin cancer	0.00031	0.00719	CbGeAlD
Cisplatin—XDH—female reproductive system—skin cancer	0.000306	0.0071	CbGeAlD
Cisplatin—GSTM1—female reproductive system—skin cancer	0.000303	0.00702	CbGeAlD
Cisplatin—NQO1—connective tissue—skin cancer	0.000301	0.00697	CbGeAlD
Cisplatin—MT1A—lymph node—skin cancer	0.000295	0.00684	CbGeAlD
Cisplatin—NQO1—epithelium—skin cancer	0.000286	0.00662	CbGeAlD
Cisplatin—ABCC6—head—skin cancer	0.000279	0.00646	CbGeAlD
Cisplatin—MPO—connective tissue—skin cancer	0.000277	0.00641	CbGeAlD
Cisplatin—NQO1—skin of body—skin cancer	0.000272	0.0063	CbGeAlD
Cisplatin—GSTP1—connective tissue—skin cancer	0.000269	0.00623	CbGeAlD
Cisplatin—PTGS2—endothelium—skin cancer	0.000265	0.00615	CbGeAlD
Cisplatin—ATP7B—lymph node—skin cancer	0.000264	0.00613	CbGeAlD
Cisplatin—MPO—epithelium—skin cancer	0.000263	0.00609	CbGeAlD
Cisplatin—SLC31A1—head—skin cancer	0.000259	0.00601	CbGeAlD
Cisplatin—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000258	0.0161	CbGpPWpGaD
Cisplatin—GSTP1—epithelium—skin cancer	0.000255	0.00592	CbGeAlD
Cisplatin—GSTM1—head—skin cancer	0.000253	0.00586	CbGeAlD
Cisplatin—MPO—skin of body—skin cancer	0.00025	0.00579	CbGeAlD
Cisplatin—NQO1—mammalian vulva—skin cancer	0.000248	0.00574	CbGeAlD
Cisplatin—PTGS2—blood vessel—skin cancer	0.000245	0.00567	CbGeAlD
Cisplatin—GSTP1—skin of body—skin cancer	0.000243	0.00563	CbGeAlD
Cisplatin—SLC31A2—Copper homeostasis—TP53—skin cancer	0.000243	0.0151	CbGpPWpGaD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—SHH—skin cancer	0.000242	0.0151	CbGpPWpGaD
Cisplatin—SLC31A2—lymph node—skin cancer	0.000241	0.0056	CbGeAlD
Cisplatin—BCHE—nipple—skin cancer	0.00023	0.00532	CbGeAlD
Cisplatin—SLC31A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000223	0.0139	CbGpPWpGaD
Cisplatin—GSTP1—mammalian vulva—skin cancer	0.000221	0.00513	CbGeAlD
Cisplatin—ATP7A—lymph node—skin cancer	0.000213	0.00493	CbGeAlD
Cisplatin—NQO1—female reproductive system—skin cancer	0.000212	0.00492	CbGeAlD
Cisplatin—MPO—lymphoid tissue—skin cancer	0.000202	0.00469	CbGeAlD
Cisplatin—SOD1—AGE/RAGE pathway—FOXO4—skin cancer	0.000197	0.0123	CbGpPWpGaD
Cisplatin—GSTP1—lymphoid tissue—skin cancer	0.000197	0.00456	CbGeAlD
Cisplatin—ABCC3—female reproductive system—skin cancer	0.00019	0.00441	CbGeAlD
Cisplatin—GSTP1—female reproductive system—skin cancer	0.00019	0.0044	CbGeAlD
Cisplatin—SOD1—lymph node—skin cancer	0.000186	0.00432	CbGeAlD
Cisplatin—CYP4A11—PPARA activates gene expression—PLIN2—skin cancer	0.000186	0.0116	CbGpPWpGaD
Cisplatin—BCHE—Peptide hormone metabolism—EXOC2—skin cancer	0.000186	0.0116	CbGpPWpGaD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000182	0.0114	CbGpPWpGaD
Cisplatin—SLC31A1—lymph node—skin cancer	0.000181	0.00421	CbGeAlD
Cisplatin—ABCC5—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000179	0.0112	CbGpPWpGaD
Cisplatin—NQO1—head—skin cancer	0.000177	0.00411	CbGeAlD
Cisplatin—GSTM1—lymph node—skin cancer	0.000177	0.0041	CbGeAlD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000164	0.0102	CbGpPWpGaD
Cisplatin—MPO—head—skin cancer	0.000163	0.00378	CbGeAlD
Cisplatin—ABCC5—Defective B3GAT3 causes JDSSDHD—CSPG4—skin cancer	0.000162	0.0101	CbGpPWpGaD
Cisplatin—ABCC3—head—skin cancer	0.000159	0.00369	CbGeAlD
Cisplatin—GSTP1—head—skin cancer	0.000158	0.00367	CbGeAlD
Cisplatin—CYP4A11—PPAR Alpha Pathway—CDK4—skin cancer	0.000158	0.00982	CbGpPWpGaD
Cisplatin—MT1A—Copper homeostasis—TP53—skin cancer	0.000156	0.00976	CbGpPWpGaD
Cisplatin—ABCC2—female reproductive system—skin cancer	0.000152	0.00353	CbGeAlD
Cisplatin—Hypotension—Vemurafenib—skin cancer	0.000151	0.00215	CcSEcCtD
Cisplatin—ABCB1—blood vessel—skin cancer	0.000151	0.00351	CbGeAlD
Cisplatin—Myocardial infarction—Bleomycin—skin cancer	0.000151	0.00214	CcSEcCtD
Cisplatin—Stomatitis—Bleomycin—skin cancer	0.00015	0.00213	CcSEcCtD
Cisplatin—Irritability—Fluorouracil—skin cancer	0.000148	0.0021	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000148	0.0021	CcSEcCtD
Cisplatin—Skin exfoliation—Docetaxel—skin cancer	0.000147	0.00209	CcSEcCtD
Cisplatin—BCHE—skin of body—skin cancer	0.000147	0.00341	CbGeAlD
Cisplatin—Convulsion—Imiquimod—skin cancer	0.000147	0.00208	CcSEcCtD
Cisplatin—Fluid retention—Docetaxel—skin cancer	0.000147	0.00208	CcSEcCtD
Cisplatin—Neuropathy—Docetaxel—skin cancer	0.000145	0.00206	CcSEcCtD
Cisplatin—Myalgia—Imiquimod—skin cancer	0.000144	0.00205	CcSEcCtD
Cisplatin—Anxiety—Imiquimod—skin cancer	0.000144	0.00204	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000143	0.00203	CcSEcCtD
Cisplatin—Discomfort—Imiquimod—skin cancer	0.000142	0.00202	CcSEcCtD
Cisplatin—Sweating increased—Temozolomide—skin cancer	0.000142	0.00201	CcSEcCtD
Cisplatin—Decreased appetite—Vemurafenib—skin cancer	0.000141	0.002	CcSEcCtD
Cisplatin—Stomatitis—Dactinomycin—skin cancer	0.00014	0.00199	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00014	0.00199	CcSEcCtD
Cisplatin—Nasopharyngitis—Fluorouracil—skin cancer	0.000139	0.00197	CcSEcCtD
Cisplatin—ATP7B—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000139	0.00866	CbGpPWpGaD
Cisplatin—Pancytopenia—Temozolomide—skin cancer	0.000138	0.00196	CcSEcCtD
Cisplatin—Oedema—Imiquimod—skin cancer	0.000138	0.00196	CcSEcCtD
Cisplatin—Infection—Imiquimod—skin cancer	0.000137	0.00195	CcSEcCtD
Cisplatin—Nervous system disorder—Imiquimod—skin cancer	0.000136	0.00192	CcSEcCtD
Cisplatin—Tachycardia—Imiquimod—skin cancer	0.000135	0.00191	CcSEcCtD
Cisplatin—MT2A—AP-1 transcription factor network—CDKN2A—skin cancer	0.000134	0.00838	CbGpPWpGaD
Cisplatin—Skin disorder—Imiquimod—skin cancer	0.000134	0.0019	CcSEcCtD
Cisplatin—BCHE—mammalian vulva—skin cancer	0.000134	0.00311	CbGeAlD
Cisplatin—Hyperhidrosis—Imiquimod—skin cancer	0.000134	0.0019	CcSEcCtD
Cisplatin—ABCC5—lymph node—skin cancer	0.000133	0.00308	CbGeAlD
Cisplatin—ABCC3—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000132	0.00823	CbGpPWpGaD
Cisplatin—Anorexia—Imiquimod—skin cancer	0.000132	0.00187	CcSEcCtD
Cisplatin—CYP2B6—skin of body—skin cancer	0.000131	0.00304	CbGeAlD
Cisplatin—Phlebitis—Docetaxel—skin cancer	0.00013	0.00185	CcSEcCtD
Cisplatin—ABCG2—mammalian vulva—skin cancer	0.00013	0.003	CbGeAlD
Cisplatin—Flushing—Bleomycin—skin cancer	0.000128	0.00182	CcSEcCtD
Cisplatin—Body temperature increased—Vemurafenib—skin cancer	0.000128	0.00182	CcSEcCtD
Cisplatin—Pancytopenia—Fluorouracil—skin cancer	0.000127	0.00181	CcSEcCtD
Cisplatin—Neuropathy peripheral—Temozolomide—skin cancer	0.000127	0.00181	CcSEcCtD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.000127	0.00792	CbGpPWpGaD
Cisplatin—Stomatitis—Temozolomide—skin cancer	0.000127	0.0018	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000126	0.00179	CcSEcCtD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000125	0.00783	CbGpPWpGaD
Cisplatin—PTGS2—connective tissue—skin cancer	0.000125	0.00291	CbGeAlD
Cisplatin—Deafness—Docetaxel—skin cancer	0.000125	0.00178	CcSEcCtD
Cisplatin—NQO1—lymph node—skin cancer	0.000124	0.00288	CbGeAlD
Cisplatin—Paraesthesia—Imiquimod—skin cancer	0.000124	0.00176	CcSEcCtD
Cisplatin—Cardiac failure congestive—Docetaxel—skin cancer	0.000124	0.00175	CcSEcCtD
Cisplatin—Dyspnoea—Imiquimod—skin cancer	0.000123	0.00175	CcSEcCtD
Cisplatin—Hepatobiliary disease—Temozolomide—skin cancer	0.000123	0.00174	CcSEcCtD
Cisplatin—Alopecia—Bleomycin—skin cancer	0.000122	0.00173	CcSEcCtD
Cisplatin—Erythema—Bleomycin—skin cancer	0.00012	0.00171	CcSEcCtD
Cisplatin—Decreased appetite—Imiquimod—skin cancer	0.00012	0.0017	CcSEcCtD
Cisplatin—Flushing—Dactinomycin—skin cancer	0.00012	0.0017	CcSEcCtD
Cisplatin—Hypersensitivity—Vemurafenib—skin cancer	0.000119	0.00169	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000119	0.00169	CcSEcCtD
Cisplatin—PTGS2—epithelium—skin cancer	0.000119	0.00276	CbGeAlD
Cisplatin—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000119	0.00742	CbGpPWpGaD
Cisplatin—ATP7B—Copper homeostasis—TP53—skin cancer	0.000119	0.0074	CbGpPWpGaD
Cisplatin—Pain—Imiquimod—skin cancer	0.000118	0.00168	CcSEcCtD
Cisplatin—ATP7A—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000118	0.00736	CbGpPWpGaD
Cisplatin—Acute coronary syndrome—Fluorouracil—skin cancer	0.000118	0.00167	CcSEcCtD
Cisplatin—Neuropathy peripheral—Fluorouracil—skin cancer	0.000117	0.00166	CcSEcCtD
Cisplatin—Myocardial infarction—Fluorouracil—skin cancer	0.000117	0.00166	CcSEcCtD
Cisplatin—Stomatitis—Fluorouracil—skin cancer	0.000117	0.00165	CcSEcCtD
Cisplatin—Conjunctivitis—Fluorouracil—skin cancer	0.000116	0.00165	CcSEcCtD
Cisplatin—Asthenia—Vemurafenib—skin cancer	0.000116	0.00165	CcSEcCtD
Cisplatin—Urinary tract disorder—Temozolomide—skin cancer	0.000115	0.00163	CcSEcCtD
Cisplatin—BCHE—female reproductive system—skin cancer	0.000115	0.00266	CbGeAlD
Cisplatin—Connective tissue disorder—Temozolomide—skin cancer	0.000115	0.00163	CcSEcCtD
Cisplatin—Urethral disorder—Temozolomide—skin cancer	0.000114	0.00162	CcSEcCtD
Cisplatin—MPO—lymph node—skin cancer	0.000114	0.00265	CbGeAlD
Cisplatin—Alopecia—Dactinomycin—skin cancer	0.000114	0.00162	CcSEcCtD
Cisplatin—Feeling abnormal—Imiquimod—skin cancer	0.000114	0.00162	CcSEcCtD
Cisplatin—PTGS2—skin of body—skin cancer	0.000113	0.00263	CbGeAlD
Cisplatin—ABCC6—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000113	0.00706	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000113	0.00706	CbGpPWpGaD
Cisplatin—Hyponatraemia—Docetaxel—skin cancer	0.000113	0.0016	CcSEcCtD
Cisplatin—Visual impairment—Temozolomide—skin cancer	0.000112	0.00159	CcSEcCtD
Cisplatin—Erythema—Dactinomycin—skin cancer	0.000112	0.00159	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000112	0.00159	CcSEcCtD
Cisplatin—Ill-defined disorder—Bleomycin—skin cancer	0.000112	0.00158	CcSEcCtD
Cisplatin—ABCC3—lymph node—skin cancer	0.000111	0.00258	CbGeAlD
Cisplatin—Anaemia—Bleomycin—skin cancer	0.000111	0.00158	CcSEcCtD
Cisplatin—GSTP1—lymph node—skin cancer	0.000111	0.00257	CbGeAlD
Cisplatin—Diarrhoea—Vemurafenib—skin cancer	0.000111	0.00157	CcSEcCtD
Cisplatin—Body temperature increased—Imiquimod—skin cancer	0.000109	0.00155	CcSEcCtD
Cisplatin—Eye disorder—Temozolomide—skin cancer	0.000109	0.00155	CcSEcCtD
Cisplatin—Tinnitus—Temozolomide—skin cancer	0.000109	0.00154	CcSEcCtD
Cisplatin—Malaise—Bleomycin—skin cancer	0.000108	0.00154	CcSEcCtD
Cisplatin—Flushing—Temozolomide—skin cancer	0.000108	0.00154	CcSEcCtD
Cisplatin—Cardiac disorder—Temozolomide—skin cancer	0.000108	0.00154	CcSEcCtD
Cisplatin—Leukopenia—Bleomycin—skin cancer	0.000108	0.00153	CcSEcCtD
Cisplatin—CYP2B6—lymphoid tissue—skin cancer	0.000106	0.00246	CbGeAlD
Cisplatin—Immune system disorder—Temozolomide—skin cancer	0.000105	0.00149	CcSEcCtD
Cisplatin—Mediastinal disorder—Temozolomide—skin cancer	0.000105	0.00149	CcSEcCtD
Cisplatin—Dehydration—Docetaxel—skin cancer	0.000104	0.00148	CcSEcCtD
Cisplatin—Ill-defined disorder—Dactinomycin—skin cancer	0.000104	0.00148	CcSEcCtD
Cisplatin—Anaemia—Dactinomycin—skin cancer	0.000104	0.00147	CcSEcCtD
Cisplatin—Vomiting—Vemurafenib—skin cancer	0.000103	0.00146	CcSEcCtD
Cisplatin—Alopecia—Temozolomide—skin cancer	0.000103	0.00146	CcSEcCtD
Cisplatin—Myalgia—Bleomycin—skin cancer	0.000102	0.00145	CcSEcCtD
Cisplatin—CYP2B6—female reproductive system—skin cancer	0.000102	0.00237	CbGeAlD
Cisplatin—Orthostatic hypotension—Docetaxel—skin cancer	0.000102	0.00145	CcSEcCtD
Cisplatin—Rash—Vemurafenib—skin cancer	0.000102	0.00145	CcSEcCtD
Cisplatin—Dermatitis—Vemurafenib—skin cancer	0.000102	0.00145	CcSEcCtD
Cisplatin—Hypersensitivity—Imiquimod—skin cancer	0.000102	0.00144	CcSEcCtD
Cisplatin—Malnutrition—Temozolomide—skin cancer	0.000101	0.00144	CcSEcCtD
Cisplatin—Erythema—Temozolomide—skin cancer	0.000101	0.00144	CcSEcCtD
Cisplatin—CYP2C9—female reproductive system—skin cancer	0.000101	0.00235	CbGeAlD
Cisplatin—Breast disorder—Docetaxel—skin cancer	0.000101	0.00144	CcSEcCtD
Cisplatin—Discomfort—Bleomycin—skin cancer	0.000101	0.00144	CcSEcCtD
Cisplatin—Malaise—Dactinomycin—skin cancer	0.000101	0.00144	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000101	0.00143	CcSEcCtD
Cisplatin—Cramp muscle—Docetaxel—skin cancer	0.000101	0.00143	CcSEcCtD
Cisplatin—ATP7A—Copper homeostasis—TP53—skin cancer	0.000101	0.00629	CbGpPWpGaD
Cisplatin—Leukopenia—Dactinomycin—skin cancer	0.0001	0.00143	CcSEcCtD
Cisplatin—Nasopharyngitis—Docetaxel—skin cancer	0.0001	0.00142	CcSEcCtD
Cisplatin—Asthenia—Imiquimod—skin cancer	9.92e-05	0.00141	CcSEcCtD
Cisplatin—Oedema—Bleomycin—skin cancer	9.82e-05	0.00139	CcSEcCtD
Cisplatin—Anaphylactic shock—Bleomycin—skin cancer	9.82e-05	0.00139	CcSEcCtD
Cisplatin—Infection—Bleomycin—skin cancer	9.76e-05	0.00138	CcSEcCtD
Cisplatin—SLC31A1—Copper homeostasis—TP53—skin cancer	9.67e-05	0.00603	CbGpPWpGaD
Cisplatin—Nausea—Vemurafenib—skin cancer	9.63e-05	0.00137	CcSEcCtD
Cisplatin—Thrombocytopenia—Bleomycin—skin cancer	9.61e-05	0.00136	CcSEcCtD
Cisplatin—Arrhythmia—Fluorouracil—skin cancer	9.6e-05	0.00136	CcSEcCtD
Cisplatin—BCHE—head—skin cancer	9.59e-05	0.00222	CbGeAlD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	9.57e-05	0.00597	CbGpPWpGaD
Cisplatin—Vision blurred—Temozolomide—skin cancer	9.56e-05	0.00136	CcSEcCtD
Cisplatin—Myalgia—Dactinomycin—skin cancer	9.55e-05	0.00136	CcSEcCtD
Cisplatin—Tremor—Temozolomide—skin cancer	9.51e-05	0.00135	CcSEcCtD
Cisplatin—Alopecia—Fluorouracil—skin cancer	9.49e-05	0.00135	CcSEcCtD
Cisplatin—MT2A—Copper homeostasis—TP53—skin cancer	9.48e-05	0.00591	CbGpPWpGaD
Cisplatin—Diarrhoea—Imiquimod—skin cancer	9.46e-05	0.00134	CcSEcCtD
Cisplatin—Discomfort—Dactinomycin—skin cancer	9.44e-05	0.00134	CcSEcCtD
Cisplatin—Ill-defined disorder—Temozolomide—skin cancer	9.42e-05	0.00134	CcSEcCtD
Cisplatin—Anaemia—Temozolomide—skin cancer	9.38e-05	0.00133	CcSEcCtD
Cisplatin—Anorexia—Bleomycin—skin cancer	9.36e-05	0.00133	CcSEcCtD
Cisplatin—Erythema—Fluorouracil—skin cancer	9.35e-05	0.00133	CcSEcCtD
Cisplatin—Pancytopenia—Docetaxel—skin cancer	9.2e-05	0.00131	CcSEcCtD
Cisplatin—Hypotension—Bleomycin—skin cancer	9.18e-05	0.0013	CcSEcCtD
Cisplatin—PTGS2—lymphoid tissue—skin cancer	9.17e-05	0.00213	CbGeAlD
Cisplatin—Oedema—Dactinomycin—skin cancer	9.16e-05	0.0013	CcSEcCtD
Cisplatin—Malaise—Temozolomide—skin cancer	9.15e-05	0.0013	CcSEcCtD
Cisplatin—Infection—Dactinomycin—skin cancer	9.1e-05	0.00129	CcSEcCtD
Cisplatin—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	9.09e-05	0.00567	CbGpPWpGaD
Cisplatin—Leukopenia—Temozolomide—skin cancer	9.08e-05	0.00129	CcSEcCtD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—skin cancer	9e-05	0.00561	CbGpPWpGaD
Cisplatin—Thrombocytopenia—Dactinomycin—skin cancer	8.97e-05	0.00127	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Bleomycin—skin cancer	8.95e-05	0.00127	CcSEcCtD
Cisplatin—ABCC2—lymph node—skin cancer	8.9e-05	0.00206	CbGeAlD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	8.87e-05	0.00553	CbGpPWpGaD
Cisplatin—PTGS2—female reproductive system—skin cancer	8.85e-05	0.00205	CbGeAlD
Cisplatin—Paraesthesia—Bleomycin—skin cancer	8.82e-05	0.00125	CcSEcCtD
Cisplatin—Vision blurred—Fluorouracil—skin cancer	8.81e-05	0.00125	CcSEcCtD
Cisplatin—Convulsion—Temozolomide—skin cancer	8.79e-05	0.00125	CcSEcCtD
Cisplatin—Vomiting—Imiquimod—skin cancer	8.79e-05	0.00125	CcSEcCtD
Cisplatin—Dyspnoea—Bleomycin—skin cancer	8.75e-05	0.00124	CcSEcCtD
Cisplatin—Anorexia—Dactinomycin—skin cancer	8.73e-05	0.00124	CcSEcCtD
Cisplatin—ABCC5—Carbohydrate metabolism—CSPG4—skin cancer	8.72e-05	0.00544	CbGpPWpGaD
Cisplatin—Rash—Imiquimod—skin cancer	8.71e-05	0.00124	CcSEcCtD
Cisplatin—Dermatitis—Imiquimod—skin cancer	8.71e-05	0.00124	CcSEcCtD
Cisplatin—Anaemia—Fluorouracil—skin cancer	8.64e-05	0.00123	CcSEcCtD
Cisplatin—Myalgia—Temozolomide—skin cancer	8.64e-05	0.00123	CcSEcCtD
Cisplatin—Anxiety—Temozolomide—skin cancer	8.61e-05	0.00122	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	8.58e-05	0.00122	CcSEcCtD
Cisplatin—CYP2B6—head—skin cancer	8.55e-05	0.00198	CbGeAlD
Cisplatin—Discomfort—Temozolomide—skin cancer	8.54e-05	0.00121	CcSEcCtD
Cisplatin—Decreased appetite—Bleomycin—skin cancer	8.54e-05	0.00121	CcSEcCtD
Cisplatin—Acute coronary syndrome—Docetaxel—skin cancer	8.51e-05	0.00121	CcSEcCtD
Cisplatin—Renal failure—Docetaxel—skin cancer	8.49e-05	0.0012	CcSEcCtD
Cisplatin—Neuropathy peripheral—Docetaxel—skin cancer	8.47e-05	0.0012	CcSEcCtD
Cisplatin—Myocardial infarction—Docetaxel—skin cancer	8.47e-05	0.0012	CcSEcCtD
Cisplatin—Stomatitis—Docetaxel—skin cancer	8.42e-05	0.00119	CcSEcCtD
Cisplatin—Pain—Bleomycin—skin cancer	8.4e-05	0.00119	CcSEcCtD
Cisplatin—Conjunctivitis—Docetaxel—skin cancer	8.39e-05	0.00119	CcSEcCtD
Cisplatin—Leukopenia—Fluorouracil—skin cancer	8.37e-05	0.00119	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dactinomycin—skin cancer	8.34e-05	0.00118	CcSEcCtD
Cisplatin—Anaphylactic shock—Temozolomide—skin cancer	8.28e-05	0.00118	CcSEcCtD
Cisplatin—Oedema—Temozolomide—skin cancer	8.28e-05	0.00118	CcSEcCtD
Cisplatin—Infection—Temozolomide—skin cancer	8.23e-05	0.00117	CcSEcCtD
Cisplatin—Nausea—Imiquimod—skin cancer	8.21e-05	0.00116	CcSEcCtD
Cisplatin—Hepatobiliary disease—Docetaxel—skin cancer	8.17e-05	0.00116	CcSEcCtD
Cisplatin—Nervous system disorder—Temozolomide—skin cancer	8.12e-05	0.00115	CcSEcCtD
Cisplatin—Thrombocytopenia—Temozolomide—skin cancer	8.11e-05	0.00115	CcSEcCtD
Cisplatin—Convulsion—Fluorouracil—skin cancer	8.1e-05	0.00115	CcSEcCtD
Cisplatin—Feeling abnormal—Bleomycin—skin cancer	8.09e-05	0.00115	CcSEcCtD
Cisplatin—Skin disorder—Temozolomide—skin cancer	8.05e-05	0.00114	CcSEcCtD
Cisplatin—Hyperhidrosis—Temozolomide—skin cancer	8.01e-05	0.00114	CcSEcCtD
Cisplatin—Myalgia—Fluorouracil—skin cancer	7.96e-05	0.00113	CcSEcCtD
Cisplatin—Decreased appetite—Dactinomycin—skin cancer	7.96e-05	0.00113	CcSEcCtD
Cisplatin—Anorexia—Temozolomide—skin cancer	7.9e-05	0.00112	CcSEcCtD
Cisplatin—Discomfort—Fluorouracil—skin cancer	7.87e-05	0.00112	CcSEcCtD
Cisplatin—Pain—Dactinomycin—skin cancer	7.83e-05	0.00111	CcSEcCtD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—skin cancer	7.8e-05	0.00487	CbGpPWpGaD
Cisplatin—Body temperature increased—Bleomycin—skin cancer	7.76e-05	0.0011	CcSEcCtD
Cisplatin—Urinary tract disorder—Docetaxel—skin cancer	7.66e-05	0.00109	CcSEcCtD
Cisplatin—Anaphylactic shock—Fluorouracil—skin cancer	7.63e-05	0.00108	CcSEcCtD
Cisplatin—Oedema—Fluorouracil—skin cancer	7.63e-05	0.00108	CcSEcCtD
Cisplatin—GSTM1—C-MYB transcription factor network—CDKN2A—skin cancer	7.63e-05	0.00476	CbGpPWpGaD
Cisplatin—Connective tissue disorder—Docetaxel—skin cancer	7.62e-05	0.00108	CcSEcCtD
Cisplatin—Urethral disorder—Docetaxel—skin cancer	7.6e-05	0.00108	CcSEcCtD
Cisplatin—Infection—Fluorouracil—skin cancer	7.58e-05	0.00108	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—skin cancer	7.55e-05	0.00107	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Temozolomide—skin cancer	7.55e-05	0.00107	CcSEcCtD
Cisplatin—Nervous system disorder—Fluorouracil—skin cancer	7.48e-05	0.00106	CcSEcCtD
Cisplatin—MT2A—AP-1 transcription factor network—TP53—skin cancer	7.47e-05	0.00466	CbGpPWpGaD
Cisplatin—Thrombocytopenia—Fluorouracil—skin cancer	7.47e-05	0.00106	CcSEcCtD
Cisplatin—Visual impairment—Docetaxel—skin cancer	7.47e-05	0.00106	CcSEcCtD
Cisplatin—Tachycardia—Fluorouracil—skin cancer	7.45e-05	0.00106	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	7.44e-05	0.00464	CbGpPWpGaD
Cisplatin—Paraesthesia—Temozolomide—skin cancer	7.44e-05	0.00106	CcSEcCtD
Cisplatin—PTGS2—head—skin cancer	7.39e-05	0.00171	CbGeAlD
Cisplatin—Dyspnoea—Temozolomide—skin cancer	7.38e-05	0.00105	CcSEcCtD
Cisplatin—ABCB1—epithelium—skin cancer	7.37e-05	0.00171	CbGeAlD
Cisplatin—Anorexia—Fluorouracil—skin cancer	7.27e-05	0.00103	CcSEcCtD
Cisplatin—Eye disorder—Docetaxel—skin cancer	7.25e-05	0.00103	CcSEcCtD
Cisplatin—Body temperature increased—Dactinomycin—skin cancer	7.24e-05	0.00103	CcSEcCtD
Cisplatin—Hypersensitivity—Bleomycin—skin cancer	7.23e-05	0.00103	CcSEcCtD
Cisplatin—Decreased appetite—Temozolomide—skin cancer	7.2e-05	0.00102	CcSEcCtD
Cisplatin—Cardiac disorder—Docetaxel—skin cancer	7.2e-05	0.00102	CcSEcCtD
Cisplatin—Flushing—Docetaxel—skin cancer	7.2e-05	0.00102	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Temozolomide—skin cancer	7.15e-05	0.00101	CcSEcCtD
Cisplatin—Hypotension—Fluorouracil—skin cancer	7.13e-05	0.00101	CcSEcCtD
Cisplatin—GSTM1—C-MYB transcription factor network—PTGS2—skin cancer	7.13e-05	0.00445	CbGpPWpGaD
Cisplatin—Pain—Temozolomide—skin cancer	7.08e-05	0.00101	CcSEcCtD
Cisplatin—Asthenia—Bleomycin—skin cancer	7.05e-05	0.001	CcSEcCtD
Cisplatin—Immune system disorder—Docetaxel—skin cancer	7e-05	0.000994	CcSEcCtD
Cisplatin—Mediastinal disorder—Docetaxel—skin cancer	6.99e-05	0.000991	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Fluorouracil—skin cancer	6.95e-05	0.000987	CcSEcCtD
Cisplatin—Arrhythmia—Docetaxel—skin cancer	6.93e-05	0.000983	CcSEcCtD
Cisplatin—Paraesthesia—Fluorouracil—skin cancer	6.85e-05	0.000972	CcSEcCtD
Cisplatin—Alopecia—Docetaxel—skin cancer	6.85e-05	0.000972	CcSEcCtD
Cisplatin—MT2A—AP-1 transcription factor network—IL6—skin cancer	6.84e-05	0.00427	CbGpPWpGaD
Cisplatin—Feeling abnormal—Temozolomide—skin cancer	6.83e-05	0.000968	CcSEcCtD
Cisplatin—Dyspnoea—Fluorouracil—skin cancer	6.8e-05	0.000965	CcSEcCtD
Cisplatin—Malnutrition—Docetaxel—skin cancer	6.75e-05	0.000958	CcSEcCtD
Cisplatin—Erythema—Docetaxel—skin cancer	6.75e-05	0.000958	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—skin cancer	6.75e-05	0.000957	CcSEcCtD
Cisplatin—BCHE—lymph node—skin cancer	6.72e-05	0.00156	CbGeAlD
Cisplatin—SOD1—Selenium Micronutrient Network—PTGS2—skin cancer	6.69e-05	0.00418	CbGpPWpGaD
Cisplatin—CYP4A11—Arachidonic acid metabolism—PTGS2—skin cancer	6.67e-05	0.00416	CbGpPWpGaD
Cisplatin—Decreased appetite—Fluorouracil—skin cancer	6.63e-05	0.000941	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Fluorouracil—skin cancer	6.59e-05	0.000935	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—skin cancer	6.57e-05	0.000932	CcSEcCtD
Cisplatin—Body temperature increased—Temozolomide—skin cancer	6.55e-05	0.000929	CcSEcCtD
Cisplatin—Pain—Fluorouracil—skin cancer	6.53e-05	0.000926	CcSEcCtD
Cisplatin—ABCG2—lymph node—skin cancer	6.49e-05	0.0015	CbGeAlD
Cisplatin—Muscle spasms—Docetaxel—skin cancer	6.49e-05	0.000921	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—CDKN2A—skin cancer	6.48e-05	0.00404	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—CDK4—skin cancer	6.46e-05	0.00403	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	6.41e-05	0.004	CbGpPWpGaD
Cisplatin—ABCB1—mammalian vulva—skin cancer	6.39e-05	0.00148	CbGeAlD
Cisplatin—ABCC5—Fluoropyrimidine Activity—TP53—skin cancer	6.39e-05	0.00398	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL6—skin cancer	6.36e-05	0.00397	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CSPG4—skin cancer	6.34e-05	0.00395	CbGpPWpGaD
Cisplatin—Feeling abnormal—Fluorouracil—skin cancer	6.29e-05	0.000892	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—skin cancer	6.27e-05	0.000889	CcSEcCtD
Cisplatin—Vomiting—Bleomycin—skin cancer	6.24e-05	0.000886	CcSEcCtD
Cisplatin—Anaemia—Docetaxel—skin cancer	6.24e-05	0.000885	CcSEcCtD
Cisplatin—Rash—Bleomycin—skin cancer	6.19e-05	0.000878	CcSEcCtD
Cisplatin—Dermatitis—Bleomycin—skin cancer	6.19e-05	0.000878	CcSEcCtD
Cisplatin—MT2A—Immune System—TLR7—skin cancer	6.15e-05	0.00383	CbGpPWpGaD
Cisplatin—Hypersensitivity—Temozolomide—skin cancer	6.1e-05	0.000866	CcSEcCtD
Cisplatin—SOD1—Copper homeostasis—TP53—skin cancer	6.07e-05	0.00379	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—PTGS2—skin cancer	6.06e-05	0.00378	CbGpPWpGaD
Cisplatin—Leukopenia—Docetaxel—skin cancer	6.04e-05	0.000857	CcSEcCtD
Cisplatin—Body temperature increased—Fluorouracil—skin cancer	6.03e-05	0.000856	CcSEcCtD
Cisplatin—Asthenia—Temozolomide—skin cancer	5.94e-05	0.000843	CcSEcCtD
Cisplatin—ABCC5—Carbohydrate metabolism—ENO2—skin cancer	5.93e-05	0.0037	CbGpPWpGaD
Cisplatin—Convulsion—Docetaxel—skin cancer	5.85e-05	0.00083	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—PTGS2—skin cancer	5.84e-05	0.00364	CbGpPWpGaD
Cisplatin—Nausea—Bleomycin—skin cancer	5.83e-05	0.000828	CcSEcCtD
Cisplatin—Vomiting—Dactinomycin—skin cancer	5.82e-05	0.000826	CcSEcCtD
Cisplatin—Rash—Dactinomycin—skin cancer	5.77e-05	0.000819	CcSEcCtD
Cisplatin—Myalgia—Docetaxel—skin cancer	5.75e-05	0.000815	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	5.71e-05	0.00081	CcSEcCtD
Cisplatin—ABCB1—lymphoid tissue—skin cancer	5.67e-05	0.00131	CbGeAlD
Cisplatin—Diarrhoea—Temozolomide—skin cancer	5.67e-05	0.000804	CcSEcCtD
Cisplatin—SOD1—Vitamin B12 Metabolism—IL6—skin cancer	5.64e-05	0.00352	CbGpPWpGaD
Cisplatin—Hypersensitivity—Fluorouracil—skin cancer	5.62e-05	0.000798	CcSEcCtD
Cisplatin—GSTT1—Metabolism—PLIN2—skin cancer	5.59e-05	0.00349	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—NRAS—skin cancer	5.55e-05	0.00346	CbGpPWpGaD
Cisplatin—Oedema—Docetaxel—skin cancer	5.51e-05	0.000782	CcSEcCtD
Cisplatin—Anaphylactic shock—Docetaxel—skin cancer	5.51e-05	0.000782	CcSEcCtD
Cisplatin—ABCB1—female reproductive system—skin cancer	5.47e-05	0.00127	CbGeAlD
Cisplatin—Infection—Docetaxel—skin cancer	5.47e-05	0.000776	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	5.44e-05	0.0034	CbGpPWpGaD
Cisplatin—Nausea—Dactinomycin—skin cancer	5.44e-05	0.000772	CcSEcCtD
Cisplatin—Nervous system disorder—Docetaxel—skin cancer	5.4e-05	0.000766	CcSEcCtD
Cisplatin—Thrombocytopenia—Docetaxel—skin cancer	5.39e-05	0.000765	CcSEcCtD
Cisplatin—Tachycardia—Docetaxel—skin cancer	5.38e-05	0.000763	CcSEcCtD
Cisplatin—Skin disorder—Docetaxel—skin cancer	5.35e-05	0.000759	CcSEcCtD
Cisplatin—Vomiting—Temozolomide—skin cancer	5.27e-05	0.000747	CcSEcCtD
Cisplatin—Anorexia—Docetaxel—skin cancer	5.25e-05	0.000745	CcSEcCtD
Cisplatin—Rash—Temozolomide—skin cancer	5.22e-05	0.000741	CcSEcCtD
Cisplatin—Diarrhoea—Fluorouracil—skin cancer	5.22e-05	0.000741	CcSEcCtD
Cisplatin—Dermatitis—Temozolomide—skin cancer	5.22e-05	0.00074	CcSEcCtD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.19e-05	0.00324	CbGpPWpGaD
Cisplatin—PTGS2—lymph node—skin cancer	5.18e-05	0.0012	CbGeAlD
Cisplatin—Hypotension—Docetaxel—skin cancer	5.15e-05	0.00073	CcSEcCtD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	5.14e-05	0.00321	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—PTGS2—skin cancer	5.11e-05	0.00318	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Docetaxel—skin cancer	5.02e-05	0.000712	CcSEcCtD
Cisplatin—SOD1—Folate Metabolism—TP53—skin cancer	5.02e-05	0.00313	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5e-05	0.00312	CbGpPWpGaD
Cisplatin—Paraesthesia—Docetaxel—skin cancer	4.95e-05	0.000702	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—CDKN2A—skin cancer	4.94e-05	0.00308	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—IL6—skin cancer	4.92e-05	0.00307	CbGpPWpGaD
Cisplatin—Nausea—Temozolomide—skin cancer	4.92e-05	0.000698	CcSEcCtD
Cisplatin—Dyspnoea—Docetaxel—skin cancer	4.91e-05	0.000697	CcSEcCtD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	4.9e-05	0.00305	CbGpPWpGaD
Cisplatin—Vomiting—Fluorouracil—skin cancer	4.85e-05	0.000688	CcSEcCtD
Cisplatin—Rash—Fluorouracil—skin cancer	4.81e-05	0.000683	CcSEcCtD
Cisplatin—Dermatitis—Fluorouracil—skin cancer	4.81e-05	0.000682	CcSEcCtD
Cisplatin—Decreased appetite—Docetaxel—skin cancer	4.79e-05	0.000679	CcSEcCtD
Cisplatin—GSTM1—C-MYB transcription factor network—KRAS—skin cancer	4.78e-05	0.00298	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Docetaxel—skin cancer	4.76e-05	0.000675	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—NRAS—skin cancer	4.72e-05	0.00294	CbGpPWpGaD
Cisplatin—Pain—Docetaxel—skin cancer	4.71e-05	0.000668	CcSEcCtD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—skin cancer	4.71e-05	0.00294	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IL6—skin cancer	4.59e-05	0.00286	CbGpPWpGaD
Cisplatin—ABCB1—head—skin cancer	4.57e-05	0.00106	CbGeAlD
Cisplatin—Feeling abnormal—Docetaxel—skin cancer	4.54e-05	0.000644	CcSEcCtD
Cisplatin—Nausea—Fluorouracil—skin cancer	4.53e-05	0.000643	CcSEcCtD
Cisplatin—GSTT1—Metabolism—CSPG4—skin cancer	4.51e-05	0.00281	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TP53—skin cancer	4.38e-05	0.00273	CbGpPWpGaD
Cisplatin—Body temperature increased—Docetaxel—skin cancer	4.35e-05	0.000618	CcSEcCtD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.25e-05	0.00265	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	4.17e-05	0.0026	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—KRAS—skin cancer	4.06e-05	0.00253	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—HRAS—skin cancer	4.06e-05	0.00253	CbGpPWpGaD
Cisplatin—Hypersensitivity—Docetaxel—skin cancer	4.06e-05	0.000576	CcSEcCtD
Cisplatin—MPO—Folate Metabolism—IL6—skin cancer	4.01e-05	0.0025	CbGpPWpGaD
Cisplatin—Asthenia—Docetaxel—skin cancer	3.95e-05	0.000561	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—CDK4—skin cancer	3.89e-05	0.00243	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.83e-05	0.00239	CbGpPWpGaD
Cisplatin—Diarrhoea—Docetaxel—skin cancer	3.77e-05	0.000535	CcSEcCtD
Cisplatin—SOD1—Selenium Micronutrient Network—IL6—skin cancer	3.65e-05	0.00227	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PLIN2—skin cancer	3.6e-05	0.00225	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—IL6—skin cancer	3.52e-05	0.0022	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—EXOC2—skin cancer	3.51e-05	0.00219	CbGpPWpGaD
Cisplatin—Vomiting—Docetaxel—skin cancer	3.5e-05	0.000497	CcSEcCtD
Cisplatin—Rash—Docetaxel—skin cancer	3.47e-05	0.000493	CcSEcCtD
Cisplatin—Dermatitis—Docetaxel—skin cancer	3.47e-05	0.000492	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—HRAS—skin cancer	3.45e-05	0.00215	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDK4—skin cancer	3.39e-05	0.00212	CbGpPWpGaD
Cisplatin—Nausea—Docetaxel—skin cancer	3.27e-05	0.000464	CcSEcCtD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	3.25e-05	0.00202	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.25e-05	0.00202	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—NRAS—skin cancer	3.22e-05	0.00201	CbGpPWpGaD
Cisplatin—ABCB1—lymph node—skin cancer	3.2e-05	0.000742	CbGeAlD
Cisplatin—MPO—Selenium Micronutrient Network—IL6—skin cancer	3.18e-05	0.00198	CbGpPWpGaD
Cisplatin—MT2A—Immune System—FOXO4—skin cancer	3.17e-05	0.00197	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—ENO2—skin cancer	3.06e-05	0.00191	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PLIN2—skin cancer	3.06e-05	0.00191	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.04e-05	0.00189	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PLIN2—skin cancer	2.98e-05	0.00186	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CDKN2A—skin cancer	2.97e-05	0.00185	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.93e-05	0.00183	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CSPG4—skin cancer	2.9e-05	0.00181	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—IL6—skin cancer	2.78e-05	0.00173	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.78e-05	0.00173	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—KRAS—skin cancer	2.77e-05	0.00173	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—TP53—skin cancer	2.75e-05	0.00171	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PLIN2—skin cancer	2.68e-05	0.00167	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	2.65e-05	0.00165	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.64e-05	0.00165	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.61e-05	0.00163	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDKN2A—skin cancer	2.59e-05	0.00162	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PLIN2—skin cancer	2.57e-05	0.0016	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—IL6—skin cancer	2.52e-05	0.00157	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.48e-05	0.00155	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CSPG4—skin cancer	2.47e-05	0.00154	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CSPG4—skin cancer	2.47e-05	0.00154	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CSPG4—skin cancer	2.41e-05	0.0015	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	2.36e-05	0.00147	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HRAS—skin cancer	2.36e-05	0.00147	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL6—skin cancer	2.26e-05	0.00141	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.23e-05	0.00139	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PLIN2—skin cancer	2.23e-05	0.00139	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CSPG4—skin cancer	2.16e-05	0.00135	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.14e-05	0.00133	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CDKN2A—skin cancer	2.11e-05	0.00131	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CDK4—skin cancer	2.1e-05	0.00131	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.08e-05	0.0013	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CSPG4—skin cancer	2.07e-05	0.00129	CbGpPWpGaD
Cisplatin—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	1.98e-05	0.00123	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ENO2—skin cancer	1.97e-05	0.00123	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.97e-05	0.00123	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PLIN2—skin cancer	1.89e-05	0.00118	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.82e-05	0.00113	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CSPG4—skin cancer	1.79e-05	0.00112	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—ERCC2—skin cancer	1.78e-05	0.00111	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—BRAF—skin cancer	1.77e-05	0.0011	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ENO2—skin cancer	1.68e-05	0.00105	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SHH—skin cancer	1.68e-05	0.00105	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ENO2—skin cancer	1.68e-05	0.00105	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—skin cancer	1.65e-05	0.00103	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ENO2—skin cancer	1.64e-05	0.00102	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	1.58e-05	0.000986	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	1.53e-05	0.000956	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CSPG4—skin cancer	1.53e-05	0.000951	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL6—skin cancer	1.51e-05	0.000945	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.48e-05	0.000923	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ENO2—skin cancer	1.47e-05	0.000915	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PLIN2—skin cancer	1.45e-05	0.000902	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—skin cancer	1.44e-05	0.0009	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.43e-05	0.000891	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.43e-05	0.00089	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ENO2—skin cancer	1.41e-05	0.000877	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FOXO4—skin cancer	1.37e-05	0.000854	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—BRAF—skin cancer	1.36e-05	0.000846	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL6—skin cancer	1.32e-05	0.000824	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	1.32e-05	0.000823	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PLIN2—skin cancer	1.3e-05	0.000814	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PLIN2—skin cancer	1.29e-05	0.000805	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NRAS—skin cancer	1.29e-05	0.000802	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ENO2—skin cancer	1.22e-05	0.00076	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—BRAF—skin cancer	1.21e-05	0.000755	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CSPG4—skin cancer	1.17e-05	0.000727	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ERCC2—skin cancer	1.15e-05	0.000715	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	1.12e-05	0.000699	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KRAS—skin cancer	1.11e-05	0.00069	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—skin cancer	1.07e-05	0.000665	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—skin cancer	1.05e-05	0.000656	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CSPG4—skin cancer	1.05e-05	0.000656	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CSPG4—skin cancer	1.04e-05	0.000649	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ENO2—skin cancer	1.04e-05	0.000647	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	1.03e-05	0.000645	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.01e-05	0.000632	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PLIN2—skin cancer	9.95e-06	0.000621	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—skin cancer	9.83e-06	0.000613	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERCC2—skin cancer	9.75e-06	0.000608	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ERCC2—skin cancer	9.75e-06	0.000608	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CSPG4—skin cancer	9.58e-06	0.000597	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PLIN2—skin cancer	9.56e-06	0.000596	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.53e-06	0.000595	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ERCC2—skin cancer	9.5e-06	0.000592	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—skin cancer	9.4e-06	0.000587	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TERT—skin cancer	9.14e-06	0.00057	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KRAS—skin cancer	9.06e-06	0.000565	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—skin cancer	8.93e-06	0.000557	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ERCC2—skin cancer	8.52e-06	0.000531	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—skin cancer	8.18e-06	0.00051	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ERCC2—skin cancer	8.17e-06	0.000509	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—skin cancer	8.14e-06	0.000508	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.11e-06	0.000506	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CSPG4—skin cancer	8.02e-06	0.0005	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ENO2—skin cancer	7.92e-06	0.000494	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CSPG4—skin cancer	7.71e-06	0.000481	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—skin cancer	7.7e-06	0.00048	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—skin cancer	7.37e-06	0.00046	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	7.27e-06	0.000453	CbGpPWpGaD
Cisplatin—ABCC5—Disease—BRAF—skin cancer	7.24e-06	0.000452	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	7.24e-06	0.000451	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ENO2—skin cancer	7.15e-06	0.000446	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ERCC2—skin cancer	7.08e-06	0.000442	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ENO2—skin cancer	7.07e-06	0.000441	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLIN2—skin cancer	7.05e-06	0.00044	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—skin cancer	6.87e-06	0.000429	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	6.84e-06	0.000426	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLIN2—skin cancer	6.59e-06	0.000411	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ENO2—skin cancer	6.51e-06	0.000406	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SHH—skin cancer	6.51e-06	0.000406	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—skin cancer	6.24e-06	0.000389	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.19e-06	0.000386	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.08e-06	0.000379	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ERCC2—skin cancer	6.02e-06	0.000376	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—skin cancer	5.85e-06	0.000365	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—skin cancer	5.84e-06	0.000365	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—skin cancer	5.7e-06	0.000355	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CSPG4—skin cancer	5.68e-06	0.000355	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—skin cancer	5.57e-06	0.000347	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ENO2—skin cancer	5.45e-06	0.00034	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CSPG4—skin cancer	5.31e-06	0.000331	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FOXO4—skin cancer	5.31e-06	0.000331	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ENO2—skin cancer	5.24e-06	0.000327	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—skin cancer	5.11e-06	0.000319	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—skin cancer	4.9e-06	0.000305	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	4.85e-06	0.000302	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ERCC2—skin cancer	4.6e-06	0.000287	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—skin cancer	4.55e-06	0.000284	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.31e-06	0.000269	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—skin cancer	4.25e-06	0.000265	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ERCC2—skin cancer	4.15e-06	0.000259	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ERCC2—skin cancer	4.11e-06	0.000256	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—skin cancer	3.92e-06	0.000244	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO2—skin cancer	3.86e-06	0.000241	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERCC2—skin cancer	3.78e-06	0.000236	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—skin cancer	3.61e-06	0.000225	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO2—skin cancer	3.61e-06	0.000225	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—skin cancer	3.54e-06	0.000221	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—skin cancer	3.33e-06	0.000208	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—skin cancer	3.19e-06	0.000199	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ERCC2—skin cancer	3.17e-06	0.000197	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ERCC2—skin cancer	3.04e-06	0.00019	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.82e-06	0.000176	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—skin cancer	2.81e-06	0.000175	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—skin cancer	2.76e-06	0.000172	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—skin cancer	2.49e-06	0.000155	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—skin cancer	2.46e-06	0.000154	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ERCC2—skin cancer	2.24e-06	0.00014	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ERCC2—skin cancer	2.1e-06	0.000131	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—skin cancer	1.82e-06	0.000114	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—skin cancer	1.76e-06	0.00011	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—skin cancer	1.52e-06	9.47e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—skin cancer	1.35e-06	8.39e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—skin cancer	1.29e-06	8.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—skin cancer	1.26e-06	7.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—skin cancer	1.24e-06	7.7e-05	CbGpPWpGaD
